LGE+ Athletes (n = 49) | LGE− Athletes (n = 44) | p-value | |
---|---|---|---|
Clinical parameters | |||
Age, years | 36 ± 6 | 35 ± 6 | 0.910 |
Female, n (%) | 19 (39) | 25 (57) | 0.216 |
Weight, kg | 68 ± 12 | 67 ± 11 | 0.643 |
Height, m | 1.7 ± 0.9 | 1.7 ± 0.2 | 0.865 |
BSA, m2 | 1.8 ± 0.2 | 1.8 ± 0.1 | 0.569 |
Peak systolic blood pressure, mm Hg | 188.5 ± 33.2 | 182.3 ± 38.1 | 0.995 |
HR, bpm | 67.5 ± 11.3 | 59.9 ± 10.9 | 0.854 |
VO2 max, ml/min/kg | 43.3 ± 8.2 | 44.0 ± 7.8 | 0.387 |
Athletic training history | |||
Active years, n | 12 ± 5 | 12 ± 7 | 0.607 |
Training load per week (METs/h/min) | 8856 ± 2959 | 7348 ± 2507 | 0.906 |
Endurance training during childhooda, n (%) | 10 (20) | 16 (36) | 0.130 |
CMR parameters | |||
LVEF, % | 57 ± 5 | 58 ± 5 | 0.372 |
LV mass indexed, g/m2 | 60 ± 12 | 61 ± 10 | 0.798 |
LVEDVI, ml/m2 | 102 ± 15 | 105 ± 14 | 0.381 |
LVESVI, ml/m2 | 43 ± 9 | 44 ± 8 | 0.792 |
LVSVI, ml/m2 | 57 ± 8 | 60 ± 9 | 0.125 |
RVEF, % | 52 ± 4 | 54 ± 6 | 0.228 |
RVEDVI, ml/m2 | 101 ± 19 | 102 ± 18 | 0.717 |
RVESVI, ml/m2 | 48 ± 10 | 47 ± 11 | 0.909 |
RVSVI, ml/m2 | 52 ± 9 | 55 ± 10 | 0.257 |